Brand CEO Alan Green discusses Feedback (FDBK) and Victoria (VCP) on the Vox Markets podcast
Brand CEO Alan Green discusses Feedback (FDBK) and Victoria (VCP) with Justin Waite on the Vox Markets podcast. The interview is 27 minutes 57 seconds in.
Feedback Chairman Dr Alastair Riddell discusses TexRAD Lung and other developments with Proactive’s Andrew Scott
Dr Alastair Riddell, chairman of Feedback (LON:FDBK) tells Proactive Investor’s Andrew Scott their TexRAD Lung product could soon be available on the diagnostic imaging platform of a leading global imaging company.
Correlation of CT Derived Texture Features with Mutational Status of Clear Cell Renal Carcinoma using TexRAD
Correlation of CT Derived Texture Features with Mutational Status of Clear Cell Renal Carcinoma using TexRAD – Preliminary Findings Presentation at Society of Abdominal Radiology (SAR) Annual Conference Sahand Sohrabi and Raghunandan Vikram – Diagnostic Imaging, MD Anderson Cancer Center, Houston, Texas, USA Purpose: To investigate role of CT Texture analysis (CTTA) and mutational status […]
Abdominal Radiology – Study using texture analysis (TexRAD) of the liver at MDCT for assessing hepatic fibrosis – Feedback plc
Abdominal Radiology – Study using texture analysis of the liver at MDCT for assessing hepatic fibrosis By Lubner MG, et al. Abdom Radiol (NY). 2017. Source PubMed. PURPOSE: To evaluate CT texture analysis (CTTA) for staging of hepatic fibrosis (stages F0-F4) METHODS: Quantitative texture analysis (QTA) of the liver was performed on abdominal MDCT scans […]
TexRAD presentation at European Congress of Radiology (ECR) – Feedback (FDBK)
Today’s presentation by Dr. Alessandro Scavuzzo from Brescia University Hospital at the European Congress of Radiology further demonstrates the utility of TexRAD on MRI in a new application in cardiovascular disorders (e.g. dilated cardiomyopathy) specifically highlighting the ability of TexRAD MR texture analysis as a non-invasive imaging biomarker showing association with the clinical score and patient […]
Feedback (FDBK) – Appointment of Joint Broker
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to announce the appointment of Northland Capital Partners Limited as joint broker to the Company with immediate effect. For further information contact: Feedback plc Alastair Riddell Tel: 01954 718072 Allenby Capital Limited (Nominated Adviser and Joint Broker) David Worlidge / James Thomas Tel: 020 […]
Brand CEO Alan Green discusses Feedback (FDBK), Advanced Oncotherapy (AVO) & Defenx (DFX) on VOX Markets podcast
Brand CEO Alan Green discusses Feedback (FDBK), Advanced Oncotherapy (AVO) & Defenx (DFX) with Justin Waite on the VOX Markets podcast. The interview is 35 minutes, 29 seconds in.
4 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
Presentation at forthcoming European Congress of Radiology (March 1-5 2017) Provided by University of Brescia. Presentation Details Presentation Title: Correlation between locally advanced HPV positive oropharyngeal squamous cell carcinoma and quantitative MRI parameters Author Block: M. Leali, E. Tononcelli, E. Lleshaj, A. Grammatica, M. Ravanelli, D. Farina, R. Maroldi; Brescia/IT (The presenting author is underlined.) Disclosure Block: M. Leali: None. E. Tononcelli: None. E. […]
3 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
Presentation at forthcoming European Congress of Radiology (March 1-5 2017) Provided by University of Brescia. Presentation Details Presentation Title: CT texture analysis as a predictor of response to therapy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors Author Block: G. Bonera, G. Agazzi, M. Ravanelli, D. Farina, V. Ferrari, A. […]
Feedback Plc (FDBK) – Interim Report for six months ended 30 November 2016
Feedback plc – Interim Report for the six months ended 30 November 2016 Chairman’s Statement We are pleased to present the interim results for the six months ended 30 November 2016. Revenue for the six months period was £203,000 (2015: £225,000) and the loss after tax was £126,000 (2015: Loss £143,000). The loss before interest, tax […]